Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
JCO Oncology Practice|March 3, 2022
Survey of US Medical Oncologists' Practices and Beliefs Regarding <i>DPYD</i> Testing Before Fluoropyrimidine ChemotherapyKyoin Koo, Amy L Pasternak, N Lynn Henry, et al.
Current Problems in Diagnostic Radiology|September 6, 2018
A Radiologist's Guide to Response Evaluation Criteria in Solid TumorsUsha R Lalchandani, Vaibhav Sahai, Katherine Hersberger, et al.
Clinical Pharmacology and Therapeutics|December 7, 2023
Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant AllelesJavier Granados, Amy L Pasternak, N Lynn Henry, et al.
ACS Omega|August 18, 2025
The Use of dSTORM-Based Single Exosome Analysis To Study Tetraspanin Abundance in Extracellular VesiclesKomal Abhange, Siobhan King, Nicole Peterson, et al.
The Oncologist|April 10, 2023
Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic TherapyValerie Gunchick, Rachel L McDevitt, Elizabeth Choi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 24, 2012
Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinomaSanjay Kakar, Guoren Deng, Thomas C Smyrk, et al.
Oncotarget|June 11, 2016
Targeting BET bromodomain proteins in solid tumorsVaibhav Sahai, Amanda J Redig, Katharine A Collier, et al.
Archives of Pathology & Laboratory Medicine|June 4, 2008
Clinicopathologic characteristics, CpG island methylator phenotype, and BRAF mutations in microsatellite-stable colorectal cancers without chromosomal instabilitySanjay Kakar, Guoren Deng, Vaibhav Sahai, et al.
World Journal of Gastrointestinal Oncology|January 23, 2020
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancersJonathan D Mizrahi, Valerie Gunchick, Kabir Mody, et al.
The Oncologist|July 22, 2024
PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinomaArathi Mohan, Elit Quingalahua, Valerie Gunchick, et al.
Pageof 11